PRAX Q1 2024 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena

PRAXPraxis Precision Medicines, Inc.

$7B

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$431,000-36.9% YoY

Gross Profit

-$27M-6160.8% margin

Operating Income

-$42M-9718.3% margin

Net Income

-$40M-9177.0% margin

EPS (Diluted)

$-2.84

QoQ Revenue Growth

-16.3%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$250M

Total Liabilities

$21M

Stockholders' Equity

$230M

Cash & Equivalents

$152M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$431,000	$683,000	-36.9%
Gross Profit	-$27M	-$25M	-7.0%
Operating Income	-$42M	-$38M	-10.0%
Net Income	-$40M	-$37M	-5.6%

Revenue Segments

License

$400,000100%